Publicaties 2011

Liu RDK, Buffart LM, Kersten MJ, Spiering M, Brug J, van Mechelen W, Chinapaw MJM. Psychometric properties of two physical activity questionnaires, the AQuAA and the PASE, in cancer patients. BMC MED RES METHODOL 2011;11:30.
 

Lowenberg B, Pabst T, Vellenga E, van Putten W, Schouten HC, Graux C, Ferrant A, Sonneveld P, Biemond BJ, Gratwohl A, de Greef GE, Verdonck LF, Schaafsma MR, Gregor M, Theobald M, Schanz U, Maertens J, Ossenkoppele GJ. Cytarabine Dose for Acute Myeloid Leukemia. NEW ENGL J MED 2011;364(11):1027-1036.

Maijenburg MW. Characterization of human mesenchymal stromak cell heterogeneity. s.l.: s.n.; 2011. (197pp.) (ISBN 9789461820204) (PhD thesis. Supervisor(s):  van der Schoot CE; co-supervisor(s):  Voermans C) [ UvA Dissertations Online ]

Mank A, van der Lelie J, de Vos R, Kersten MJ. Safe early discharge for patients undergoing high dose chemotherapy with or without stem cell transplantation: a prospective analysis of clinical variables predictive for complications after treatment. J CLIN NURS 2011;20(3-4):388-395.     [ PubMed ]

Meijer E, Janssen JJWM, Huisman C, Petersen EJ, Coenen JLLM, von dem Borne PA. Complicatieregistratie na hematopoëtische stamceltransplantaties. NED TIJDSCHR HEMATOL 2011;8(1):7-13.  

Minnema MC, van Dorp S, van de Donk NWCJ, Schouten F, Kersten MJ , Coenen JLLM, Schouten H, Zweegman S, Schaafsma R, Lokhorst HM. Prognostic factors and outcome in relapsed multiple myeloma after nonmyeloablative allo-SCT: a single center experience. BONE MARROW TRANSPL 2011;46(2):244-249.     [ PubMed ]

Mohr J, Helfrich H, Fuge M, Eldering E, Bühler A, Winkler D, Volden M, Kater AP, Mertens D, te Raa D, Döhner H, Stilgenbauer S, Zenz T. DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing. BLOOD 2011;117(5):1622-1632.     [ PubMed ]

Nur E. Vasculopathy in sickle cell disease. s.l.: s.n.; 2011. (211pp.) (ISBN 9789090260877) (PhD thesis. Supervisor(s):  van Oers MHJ; co-supervisor(s):  Biemond BJ, Brandjes DPM) [ UvA Dissertations Online ]

Nur E, Biemond BJ, Otten HM, Brandjes DP, Schnog JJB. Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management. AM J HEMATOL 2011;86(6):484-489.     [ PubMed ]

Nur E, van Beers EJ, Martina S, Cuccovillo I, Otten HM, Schnog JJB, Meijers JCM, Mantovani A, Brandjes DP, Bottazzi B, Biemond BJ. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis. BLOOD CELL MOL DIS 2011;46(3):189-194.     [ PubMed ]

Nur E, Verwijs M, de Waart DR, Schnog JJB, Otten HM, Brandjes DP, Biemond BJ, Elferink RPJO. Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes. BBA-MOL BASIS DIS 2011;1812(11):1412-1417.     [ PubMed ]

Persoon S, Kersten MJ , Chinapaw MJM, Brug J, Nollet F. EXercise Intervention after Stem cell Transplantation (EXIST). NED TIJDSCHR HEMATOL 2011;8(3):125-129.  

Raa GDT, Fischer K, Verweij W, van Houte AJ, Kater AP, Biesma DH. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis. CLIN CHEM LAB MED 2011;49(1):115-120.  

Rijneveld AW, van der Holt B, Daenen SMGJ, Biemond BJ, de Weerdt O, Muus P, Maertens J, Mattijssen V, Demuynck H, Legdeur MCJC, Wijermans PW, Wittebol S, Spoelstra FM, Dekker AW, Ossenkoppele GJ, Willemze R, Cornelissen JJ. Intensified chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40. LEUKEMIA 2011;25(11):1697-1703.  

Ruinemans-Koerts J, Boonstra JG, Klasen IS, Zweegman S, Minnema MC, Wegman JJ, Kersten MJ , Dinkelaar RB, Wijermans P, Raymakers RAP. Laboratoriumonderzoek bij monoklonale gammopathie: detectie van monoklonale immuunglobulinen. NED TIJDSCHR HEMATOL 2011;8(4):160.  

Salles G, de Jong D, Xie W, Rosenwald A, Chhanabhai M, Gaulard P, Klapper W, Calaminici M, Sander B, Thorns C, Campo E, Molina T, Lee A, Pfreundschuh M, Horning S, Lister A, Sehn LH, Raemaekers J, Hagenbeek A, Gascoyne RD, Weller E. Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium. BLOOD 2011;117(26):7070-7078.     [ PubMed ]

Salles G, Seymour JF, Offner F, López-Guillermo A, Belada D, Xerri L, Feugier P, Bouabdallah R, Catalano JV, Brice P, Caballero D, Haioun C, Pedersen LM, Delmer A, Simpson D, Leppa S, Soubeyran P, Hagenbeek A, Casasnovas O, Intragumtornchai T, Fermé C, da Silva MG, Sebban C, Lister A, Estell JA, Milone G, Sonet A, Mendila M, Coiffier B, Tilly H. Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. LANCET 2011;377(9759):42-51.     [ PubMed ]

Scheffer PG, Ait Soussan A, Verhagen OJHM, Page-Christiaens GCML, Oepkes D, de Haas M, van der Schoot CE. Noninvasive fetal genotyping of human platelet antigen-1a. BJOG-INT J OBSTET GY 2011;118(11):1392-1395.     [ PubMed ]

Scheffer PG, de Haas M, van der Schoot CE. The controversy about controls for fetal blood group genotyping by cell-free fetal DNA in maternal plasma. CURR OPIN HEMATOL 2011;18(6):467-473.     [ PubMed ]

Scheffer PG, van der Schoot CE, Page-Christiaens GCML, de Haas M. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG-INT J OBSTET GY 2011;118(11):1340-1348.     [ PubMed ]

Speksnijder HT, Mank AP, van Achterberg T. Nursing Diagnoses (NANDA-I) in Hematology-Oncology: A Delphi-Study. INT J NURS TERMINOL CLASSIF 2011;22(2):77-91.     [ PubMed ]

Stapleton NM, Andersen JT, Stemerding AM, Bjarnarson SP, Verheul RC, Gerritsen J, Zhao Y, Kleijer M, Sandlie I, de Haas M, Jonsdottir I, van der Schoot CE, Vidarsson G. Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. NAT COMMUN 2011;2:599.     [ PubMed ]

Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, Wuillemin WA, Aarden LA, Zeerleder S. Activation of factor VII-activating protease in human inflammation: a sensor for cell death. CRIT CARE 2011;15(2):R110.     [ PubMed ]

Stutterheim J. Minimal residual disease detection and monitoring in children with neuroblastoma. s.l.: s.n.; 2011. (221pp.) (ISBN 9789490371869) (PhD thesis. Supervisor(s):  Caron HN, van der Schoot CE; co-supervisor(s):  Tytgat GAM) [ UvA Dissertations Online ]

Stutterheim J, Zappeij-Kannegieter L, Versteeg R, Caron HN, van der Schoot CE, Tytgat GAM. The prognostic value of fast molecular response of marrow disease in patients aged over 1 year with stage 4 neuroblastoma. EUR J CANCER 2011;47(8):1193-1202.     [ PubMed ]

Thai KTD, Wismeijer JA, Zumpolle C, de Jong MD, Kersten MJ , de Vries PJ. High incidence of peripheral blood plasmacytosis in patients with dengue virus infection. CLIN MICROBIOL INFEC 2011;17(12):1823-1828.     [ PubMed ]

Tonino SH. Targets for the treatment of drug resistant chronic lymphocytic leukemia. s.l.: s.n.; 2011. (175pp.) (ISBN 9789090264820) (PhD thesis. Supervisor(s):  van Oers MHJ; co-supervisor(s):  Kater AP , Eldering E) [ UvA Dissertations Online ]

Tonino SH, Rijssenbeek AL, Oud ME, Pals ST, van Oers MH, Kater AP. Intracerebral Infiltration As the Unique Cause of the Clinical Presentation of Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia. J CLIN ONCOL 2011;29(34):E837-E839.     [ PubMed ]

Tonino SH, van Laar J, van Oers MH, Wang JY, Eldering E, Kater AP. ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. ONCOGENE 2011;30(6):701-713.     [ PubMed ]

Tuinman PR, Nieuwenhuis MBB, Groen E, Kersten MJ. A young woman with generalised lymphadenopathy. Systemic lupus erythematosus (SLE). NETH J MED 2011;69(6):284-288.     [ PubMed ]

van der Helm LH, Alhan C, Wijermans PW, Kooy MVM, Schaafsma R, Biemond BJ, Beeker A, Hoogendoorn M, van Rees BP, de Weerdt O, Wegman J, Libourel WJ, Luykx-de Bakker SA, Minnema MC, Brouwer RE, Boer FCD, Eefting M, Jie KSG, de Loosdrecht AAV, Koedam J, Veeger NJGM, Vellenga E, Huls G. Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme. BRIT J HAEMATOL 2011;155(5):599-606.
 

van der Laan AM, Hirsch A, Haeck JDE, Nijveldt R, Delewi R, Biemond BJ, Tijssen JGP, Marques KMJ, Zijlstra F, van Rossum AC, Piek JJ. Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial. JACC-CARDIOVASC INT 2011;4(8):913-920.     [ PubMed ]

van der Plas EM, van den Tweel XW, Geskus RB, Heijboer H, Biemond BJ, Peters M, Fijnvandraat K. Mortality and causes of death in children with sickle cell disease in the Netherlands, before the introduction of neonatal screening. BRIT J HAEMATOL 2011;155(1):106-110.     [ PubMed ]

van der Straaten HM, Paquay MM, Tilanus MGJ, van Geloven N, Verdonck LF, Huisman C. NOD2/CARD15 Variants Are Not a Risk Factor for Clinical Outcome after Nonmyeloablative Allogeneic Stem Cell Transplantation. BIOL BLOOD MARROW TR 2011;17(8):1231-1236.  

van Meerten T, Hagenbeek A. Novel antibodies against follicular non-Hodgkin's lymphoma. BEST PRACT RES CL HA 2011;24(2):231-256.     [ PubMed ]

van Oers MHJ, Jansen JH, van der Reijden BA. Molecular Remission in Follicular Lymphoma: Is the Era of Residual Disease Monitoring Over? Reply. J CLIN ONCOL 2011;29(11):E319.  

van Oers MHJ, Kersten MJ. Treatment strategies in advanced stage follicular lymphoma. BEST PRACT RES CL HA 2011;24(2):187-201.     [ PubMed ]

Veldhuisen B, Ligthart PC, Vidarsson G, Roels I, Folman CC, van der Schoot CE, de Haas M. Molecular analysis of the York antigen of the Knops blood group system. TRANSFUSION 2011;51(7):1389-1396.     [ PubMed ]

Vermoolen MA, Kersten MJ, Fijnheer R, van Leeuwen MS, Kwee TC, Nievelstein RAJ. Magnetic resonance imaging of malignant lymphoma. EXPERT REV HEMATOL 2011;4(2):161-171.  

Vlaar APJ, Rietdijk ST, Zeerleder SS, Boerman T, Beuers U. Malignancies associated with chronic hepatitis C: case report and review of the literature. NETH J MED 2011;69(5):211-215.     [ PubMed ]

Vos JMI, Bordbar A, Vet R, Pals ST, Kater AP. Waxing and waning intravascular large cell lymphoma with widespread organ infiltration. LEUKEMIA LYMPHOMA 2011;52(4):705-708.     [ PubMed ]

Waanders E, van der Velden VHJ, van der Schoot CE, van Leeuwen FN, van Reijmersdal SV, de Haas V , Veerman AJ, van Kessel AG, Hoogerbrugge PM, Kuiper RP, van Dongen JJM. Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia. LEUKEMIA 2011;25(2):254-258.     [ PubMed ]

Windt GJWvd, Schouten M, Zeerleder S, Florquin S, Poll Tvd. CD44 Is Protective during Hyperoxia-Induced Lung Injury. AM J RESP CELL MOL 2011;44(3):377-383.     [ PubMed ]

Younes A, Hagenbeek A, Coiffier B. Optimising the lymphoma response criteria in the era of targeted therapy. LANCET ONCOL 2011;12(7):616-617.     [ PubMed ]

Zeerleder S. Autoimmune haemolytic anaemia - a practical guide to cope with a diagnostic and therapeutic challenge. NETH J MED 2011;69(4):177-184.     [ PubMed ]

Zeerleder S. C1-inhibitor: more than a serine protease inhibitor. SEMIN THROMB HEMOST 2011;37(4):362-374.     [ PubMed ]

Zweegman S, Minnema MC, Stevens-Kroef M, Kersten MJ , Wijermans P, Wegman JJ, Regelink JC, Brooimans RA, Beverloo B, Bloem AC, Lokhorst HM, Sonneveld P, Raymakers RAP. Diagnostiek bij multipel myeloom: de rol van beeldvorming, chromosoomanalyse en multiparameterflowcytometrie. NED TIJDSCHR HEMATOL 2011;8(4):146.  

[Investigators: Butterworth AS, Braund PS, Farrall M, Hardwick RJ, Saleheen D, Peden JF, Soranzo N, Chambers JC, Sivapalaratnam S, Kleber ME, Keating B, Qasim A, Klopp N, Erdmann J, Assimes TL, Ball SG, Balmforth AJ, Barnes TA, Basart H, Baumert J, Bezzina CR, Boerwinkle E, Boehm BO, Brocheton J, Bugert P, Cambien F, Clarke R, Codd V, Collins R, Couper D, Cupples LA, de Jong JS, Diemert P, Ejebe K, Elbers CC, Elliott P, Fornage M, Franzosi MG, Frossard P, Garner S, Goel A, Goodall AH, Hengstenberg C, Hunt SE, Kastelein JJP, Klungel OH, Klüter H, Koch K, König IR, Kooner AS, Laaksonen R, Lathrop M, Li M, Liu K, McPherson R, Musameh MD, Musani S, Nelson CP, O'Donnell CJ, Ongen H, Papanicolaou G, Peters A, Peters BJM, Potter S, Psaty BM, Qu L, Rader DJ, Rasheed A, Rice C, Scott J, Seedorf U, Sehmi JS, Sotoodehnia N, Stark K, Stephens J, van der Schoot CE, van der Schouw YT, Thorsteinsdottir U, Tomaszewski M, van der Harst P, Vasan RS, Wilde AAM, Willenborg C, Winkelmann BR, Zaidi M, Zhang W, Ziegler A, de Bakker PIW, Koenig W, Mätz W, Trip MD, Reilly MP, Kathiresan S, Schunkert H, Hamsten A, Hall AS, Kooner JS, Thompson SG, Thompson JR, Deloukas P, Ouwehand WH, Watkins H, Danesh J, Samani NJ, Barnes T, Rafelt S, Bruinsma N, Dekker LR, Henriques JP, Koch KT, de Winter RJ, Alings M, Allaart CF, Gorgels AP, Verheugt FW, Mueller M, Meisinger C, DerOhannessian S, Mehta NN, Ferguson J, Hakonarson H, Matthai W, Wilensky R, Hopewell JC, Parish S, Linksted P, Notman J, Gonzalez H, Young A, Ostley T, Munday A, Goodwin N, Verdon V, Shah S, Cobb L, Edwards C, Mathews C, Gunter R, Benham J, Davies C, Cobb M, Crowther J, Richards A, Silver M, Tochlin S, Mozley S, Clark S, Radley M, Kourellias K, Silveira A, Söderholm B, Olsson P, Barlera S, Tognoni G, Rust S, Assmann G, Heath S, Zelenika D, Gut I, Green F, Peden J, Aly A, Anner K, Björklund K, Blomgren G, Cederschiöld B, Danell-Toverud K, Eriksson P, Grundstedt U, Heinonen M, Hellénius ML, van't Hooft F, Husman K, Lagercrantz J, Larsson A, Larsson M, Mossfeldt M, Mälarstig A, Olsson G, Sabater-Lleal M, Sennblad B, Strawbridge R, Öhrvik J, Zaman KS, Mallick NH, Azhar M, Samad A, Ishaq M, Shah N, Samuel M, Reilly M, Holm H, Preuss M, Stewart AFR, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand S, Andersen K, Anderson JL, Ardissino D, Becker LC, Becker DM, Berger K, Bis JC, Boekholdt SM, Brown MJ, Burnett MS, Buysschaert I, Carlquist JF, Chen L, Davies RW, Dedoussis G, Dehghan A, Demissie S, Devaney J, Do R, Doering A, El Mokhtari NE, Ellis SG, Elosua R, Engert JC, Epstein S, de Faire U, Fischer M, Folsom AR, Freyer J, Gigante B, Girelli D, Gretarsdottir S, Gudnason V, Gulcher JR, Tennstedt S, Halperin E, Hammond N, Hazen SL, Hofman A, Horne BD, Illig T, Iribarren C, Jones GT, Jukema JW, Kaiser MA, Kaplan LM, Khaw KT, Knowles JW, Kolovou G, Kong A, Lambrechts D, Leander K, Lieb W, Lettre G, Loley C, Lotery AJ, Mannucci PM, Maouche S, Martinelli N, McKeown PP, Meitinger T, Melander O, Merlini PA, Mooser V, Morgan T, Mühleisen TW, Muhlestein JB, Musunuru K, Nahrstaedt J, Nöthen MM, Olivieri O, Peyvandi F, Patel RS, Patterson CC, Quyyumi AA, Rallidis LS, Roosendaal FR, Rubin D, Salomaa V, Sampietro ML, Sandhu MS, Schadt E, Schäfer A, Schillert A, Schreiber S, Schrezenmeir J, Schwartz SM, Siscovick DS, Sivananthan M, Smith AV, Smith TB, Snoep JD, Spertus JA, Stefansson K, Stirrups K, Stoll M, Tang WHW, Thorgeirsson G, Thorleifsson G, Uitterlinden AG, van Rij AM, Voight BF, Wareham NJ, AWells G, Wichmann HE, Witteman JCM, Wright BJ, Ye S, Quertermous T, März W, Blankenberg S, Roberts R, Onland-Moret NC, van Setten J, Verschuren WMM, Boer JMA, Wijmenga C, Hofker MH, Maitland-van der Zee AH, de Boer A, Grobbee DE, Attwood T, Belz S, Braund P, Cambien F, Cooper J, Crisp-Hihn A, Foad N, Gracey J, Gray E, Gwilliams R, Heimerl S, Jolley J, Krishnan U, Lloyd-Jones H, Lugauer I, Lundmark P, Moore JS, Muir D, Murray E, Nelson CP, Neudert J, Niblett D, O'Leary K, Pollard H, Rankin A, Rice CM, Sager H, Sambrook J, Schmitz G, Scholz M, Schroeder L, Syvannen AC, Wallace C]. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLOS GENET 2011;7(9):e1002260.     [ PubMed ]